Prostaglandin E 2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 3, 2012, Pages 604-611

  Iwanaga, Koichi ^a   Okada, Muneyoshi ^a   Murata, Takahisa ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GENISTEIN; INDOMETACIN; MESSENGER RNA; ORANTINIB; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; FIBROBLAST GROWTH FACTOR 2; PROSTAGLANDIN E RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYCLOOXYGENASE 1 GENE; CYCLOOXYGENASE 2 GENE; ENZYME MECHANISM; FIBROBLAST GROWTH FACTOR 2 GENE; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; INTESTINE EPITHELIUM CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN E RECEPTOR 2 GENE; PROSTAGLANDIN E RECEPTOR 3 GENE; PROSTAGLANDIN E RECEPTOR 4 GENE; PROSTAGLANDIN E2 RECEPTOR GENE; PROSTAGLANDIN RELEASE; PROTEIN SECRETION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; CATTLE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; GENETICS; INTESTINE MUCOSA; PHYSIOLOGY;

ANIMALS; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLAST GROWTH FACTOR 2; INTESTINAL MUCOSA; MYOFIBROBLASTS; PROTEIN-TYROSINE KINASES; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; WOUND HEALING;

EID: 84857258046     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.189845     Document Type: Article

References (39)

1. Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, and Jabbour HN (2007) Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor- mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 22:36-44. (Pubitemid 44942664)
2. Blikslager AT, Moeser AJ, Gookin JL, Jones SL, and Odle J (2007) Restoration of barrier function in injured intestinal mucosa. Physiol Rev 87:545-564. (Pubitemid 47084680)
3. Bowman CC and Bost KL (2004) Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J Immunol 172:2469-2475. (Pubitemid 38182397)
4. Bradbury D, Clarke D, Seedhouse C, Corbett L, Stocks J, and Knox A (2005) Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J Biol Chem 280:29993-30000. (Pubitemid 41216174)
5. Cheng T, Cao W, Wen R, Steinberg RH, and LaVail MM (1998) Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. Invest Ophthalmol Vis Sci 39:581-591. (Pubitemid 28110692)
6. Davids JS, Carothers AM, Damas BC, and Bertagnolli MM (2010) Chronic cyclooxygenase- 2 inhibition promotes myofibroblast-associated intestinal fibrosis. Cancer Prev Res (Phila) 3:348-358.
7. Degagné E, Grbic DM, Dupuis AA, Lavoie EG, Langlois C, Jain N, Weisman GA, Sévigny J, and Gendron FP (2009) P2Y2 receptor transcription is increased by NF-κB and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J Immunol 183:4521-4529.
8. Di Sabatino A, Pender SL, Jackson CL, Prothero JD, Gordon JN, Picariello L, Rovedatti L, Docena G, Monteleone G, Rampton DS, et al. (2007) Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 133:137-149. (Pubitemid 47031137)
9. Eligini S, Arenaz I, Barbieri SS, Faleri ML, Crisci M, Tremoli E, and Colli S (2009) Cyclooxygenase-2 mediates hydrogen peroxide-induced wound repair in human endothelial cells. Free Radic Biol Med 46:1428-1436.
10. Fornai M, Blandizzi C, Antonioli L, Colucci R, Bernardini N, Segnani C, De Ponti F, and Del Tacca M (2006) Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation. J Pharmacol Exp Ther 317:938-945. (Pubitemid 43764095)
11. Francoeur C, Bouatrouss Y, Seltana A, Pinchuk IV, Vachon PH, Powell DW, Sawan B, Seidman EG, and Beaulieu JF (2009) Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology 136:268-277.e3.
12. Furuya K, Sokabe M, and Furuya S (2005) Characteristics of subepithelial fibroblasts as a mechano-sensor in the intestine: cell-shape-dependent ATP release and P2Y1 signaling. J Cell Sci 118:3289-3304. (Pubitemid 41246086)
13. Gavala ML, Hill LM, Lenertz LY, Karta MR, and Bertics PJ (2010) Activation of the transcription factor FosB/activating protein-1 (AP-1) is a prominent downstream signal of the extracellular nucleotide receptor P2RX7 in monocytic and osteoblastic cells. J Biol Chem 285:34288-34298.
14. Goldmann O, Hertzén E, Hecht A, Schmidt H, Lehne S, Norrby-Teglund A, and Medina E (2010) Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. J Immunol 185:2372-2381.
15. Hata AN and Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147-166. (Pubitemid 39209041)
16. Hatane T, Yoshida E, Kawano J, Sugiki M, Onitsuka T, and Maruyama M (1998) Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast. Biochim Biophys Acta 1403:189-198. (Pubitemid 28308271)
17. Hill LM, Gavala ML, Lenertz LY, and Bertics PJ (2010) Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 185:3028-3034.
18. Ikeda-Matsuo Y, Hirayama Y, Ota A, Uematsu S, Akira S, and Sasaki Y (2010) Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity. Br J Pharmacol 159:1174-1186.
19. Iovine B, Iannella ML, Gasparri F, Monfrecola G, and Bevilacqua MA (2011) Synergic effect of genistein and daidzein on UVB-induced DNA damage: an effective photoprotective combination. J Biomed Biotechnol 2011:692846.
20. Iwanaga K, Murata T, Hori M, and Ozaki H (2010) Isolation and characterization of bovine intestinal subepithelial myofibroblasts. J Pharmacol Sci 112:98-104.
21. Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B, et al. (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119:512-523.
22. Jiang GL, Im WB, Donde Y, and Wheeler LA (2009) EP4 agonist alleviates indomethacin- induced gastric lesions and promotes chronic gastric ulcer healing. World J Gastroenterol 15:5149-5156.
23. Kernochan LE, Tran BN, Tangkijvanich P, Melton AC, Tam SP, and Yee HF Jr (2002) Endothelin-1 stimulates human colonic myofibroblast contraction and migration. Gut 50:65-70. (Pubitemid 34028305)
24. Kobayashi K, Murata T, Hori M, and Ozaki H (2011) Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 660:375-380.
25. Lee IY, Bae YD, Jeoung DI, Kang D, Park CH, Kim SH, and Choe J (2007) Prostacyclin production is not controlled by prostacyclin synthase but by cyclooxygenase- 2 in a human follicular dendritic cell line, HK. Mol Immunol 44:3168-3172. (Pubitemid 46610505)
26. Li G, Chen YF, Greene GL, Oparil S, and Thompson JA (1999) Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation 100:1639-1645. (Pubitemid 29477274)
27. Li YJ, Wang XQ, Sato T, Kanaji N, Nakanishi M, Kim M, Michalski J, Nelson AJ, Sun JH, Farid M, et al. (2011) Prostaglandin E2 inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors. Am J Respir Cell Mol Biol 44:99-107.
28. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
29. Mahida YR, Beltinger J, Makh S, Göke M, Gray T, Podolsky DK, and Hawkey CJ (1997) Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol Gastrointest Liver Physiol 273:G1341-G1348.
30. Peskar BM (2005) Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 13:15-26.
31. Radi ZA and Khan NK (2005) Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 54:358-366.
32. Regan JW (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci 74:143-153.
33. Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, and Ellis LM (2001) Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15:1239-1241.
34. Sakai Y, Fujita K, Sakai H, and Mizuno K (2001) Prostaglandin E2 regulates the expression of basic fibroblast growth factor messenger RNA in normal human fibroblasts. Kobe J Med Sci 47:35-45. (Pubitemid 32862069)
35. Shao J, Sheng GG, Mifflin RC, Powell DW, and Sheng H (2006) Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res 66:846-855. (Pubitemid 43165950)
36. 2and prostaglandin E2. J Pharmacol Exp Ther 326:493-501.
37. Takeuchi K, Tanigami M, Amagase K, Ochi A, Okuda S, and Hatazawa R (2010) Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through up-regulation of vascular endothelial growth factor expression by activation of EP4 receptors. J Gastroenterol Hepatol 25 (Suppl 1):S67-S74.
38. Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, and Mizushima T (2009) Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol 603:120-132.
39. Zhang L, Himi T, and Murota S (2000) Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E2. J Neurosci Res 62:389-395.